Market Research Blog – Page 3731 – New Product Development

Revolutionizing Calf Nutrition The Surging Demand for Calf Milk Replacers in a US$ 7.25 Billion Market by 2032

The Calf Milk Replacers Market is expected to grow at a compound annual growth rate (CAGR) of 7.5% over the forecast period, from US$ 2.45 billion in 2021 to US$ 7.25 billion in 2032, as a result of increased focus on creating nutrient-rich formula with benefits for health.

The market for calf milk substitutes is The market share is expected to grow at a compound annual growth rate (CAGR) of 7.5% from US$2.45 billion in 2021 to US$7.25 billion in 2032 as a result of the increased focus on nutrient production. nourishing concoction that has positive health effects Calf milk replacers have become quite popular since they are less expensive, easier to use, and more effective than complete cow’s milk at stopping the spread of disease through milk.

Recent studies have shown that nutrient intake from these products boosts pre-weaning average daily gain and future milk production, which has increased demand for calf milk replacers. In the near future, it is anticipated that the calf milk replacer market would expand gradually as manufacturers concentrate on creating novel formulation choices that assist calves in receiving all the nutrients they require.

Unlock the Secrets of Calf Nutrition: Get a Taste of Our Exclusive Sample Report :
https://www.futuremarketinsights.com/reports/sample/rep-gb-9915

Key Factors Shaping Calf Milk Replacers Market

Exponential Increase in Demand for Dairy Products

Over the years, the demand for dairy products, ranging from milk and butter to protein-enriched drinks, has been moving on an upward spiral, on account of several factors such as significant improvements in domestic and international economic conditions and widespread awareness of nutritional values of these products. This, in turn, continues to augment the demand for calf milk replacers which provide digestible protein, fortified vitamins, and essential trace minerals for optimal absorption and utilization.

In the future, population growth, continued urbanization, and climate change are expected to place added pressure on global food production systems. Dairy farms will need to be profitable yet sustainable, thereby compelling key players in the calf milk replacers market to redefine their product innovation and development strategies.

Focus on Producing Nutrient-enriched Formula with Health-supporting Benefits

As demand for dairy products is on a significant rise, farmers are continually adopting technologies and practices that provide improved cow health, longevity, and profitable dairy farms. Whole milk contains a range of bioactive components such as growth enzymes and hormones, and has higher energy content as compared to calf milk replacers.

To compensate the differences in energy supply, manufacturers are focusing on introducing nutrient-rich ingredients that help improve digestion, strengthen immunity, optimize gut pH, and maintain gut integrity of calves. In addition, several strategies, such as higher feeding rates and modifying calf milk replacer composition to increase nutrient intake, have been used to accelerate the growth rate of calves during the milk phase.

Rise of Organic Dairy Farming and Vegan Culture to Impede Market Growth

While the world is facing a challenge in feeding its expanding population, emergence of organic and vegan trend has brought a radical upheaval in the dairy industry. In organic dairy farming, both farmers and consumers are increasingly asking for more natural calf rearing method over bucket-feeding, which is expected to create a hindrance in sales of calf milk replacers. With rise in popularity of organic milk, consumers’ interest in organic cheese and organic ice creams is increasing, thereby negatively impacting the market growth. Additionally, growing animal welfare concerns has influenced consumers to shift away from animal-based products to plant-based products. An increase in adoption of vegan diet is expected to challenge the future sales of dairy products, and subsequently demand for calf milk replacers.

Embrace the Dairy Revolution: Buy Now to Navigate the Changing Landscape of Calf Milk Replacers :
https://www.futuremarketinsights.com/checkout/9915

Calf Milk Replacers Market Players – Notable Developments

Some of the key players operating in the calf milk replacers market include Land O’Lakes, Inc., SHV Holdings N.V., Calva Products Co., Inc., Groupe Lactalis S.A., Glanbia plc, Cargill, Incorporated, Liprovit BV, PBI/Gordon Corporation, CHS Inc., Royal FrieslandCampina N.V., and Archer-Daniels-Midland Company.

In October 2019, Royal Friesland Campina N.V. announced that it has entered into an agreement with Royal A-ware to expand its production and supply of mozzarella cheese. In addition to supplying milk, knowledge, and recipes, the former company will be responsible for sale of mozzarella cheese. Whereas, the latter is set to monitor the processing of milk and production of mozzarella cheese.
In September 2019, Cargill Inc. announced reorganization of its animal nutrition business, as a response to growing concerns about animal health and wellness. The company added a new unit, ‘Cargill Health Technologies’ to its animal nutrition and health group consisting of Cargill Animal Nutrition and Cargill Aqua Nutrition.
In June 2019, Land O’Lakes, Inc. partnered with Netherlands-based Royal Agrifirm Group to set up a dairy animal feed joint venture – Agrilakes – in China. The new company is aimed at leveraging existing market knowledge, technologies and research capabilities from both the companies to provide world-class service to feed customers and dairy farmers in China.

The report covers exhaustive analysis on:

Calf Milk Replacers Market Segments
Market Dynamics
Calf Milk Replacers Market Size
Supply and Demand
Current Trends/Issues/Challenges pertaining to Calf Milk Replacers Market
Competition Landscape and Emerging Market Participants in Calf Milk Replacers Market
Technology related to Production/Processing of Calf Milk Replacers
Value Chain Analysis of the Calf Milk Replacers Market

The regional analysis includes:

North America (U.S., Canada)
Latin America (Mexico, Brazil)
Europe (Germany, U.K., France, Italy, Spain, Poland, Russia)
East Asia (China, Japan, South Korea)
South Asia (India, Thailand, Malaysia, Vietnam, Indonesia)
Oceania (Australia, New Zealand)
Middle East & Africa (GCC Countries, Turkey, Northern Africa, South Africa)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Nandini Singh Sawlani
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Excimer and Femtosecond Ophthalmic Lasers Market Set to Eclipse US$ 2.41 Billion by 2032, Illuminating Future Vision Technologies

The Excimer and Femtosecond Ophthalmic Lasers Market represents a transformative segment in the field of ophthalmology, offering advanced and precise solutions for various vision correction procedures. Excimer lasers have been widely used for decades in refractive surgeries like LASIK (Laser-Assisted In Situ Keratomileusis), providing patients with improved visual acuity and reduced dependency on glasses or contact lenses. On the other hand, femtosecond lasers have gained prominence for their remarkable ability to create precise corneal incisions during cataract surgery and corneal transplant procedures. As the demand for minimally invasive and highly accurate eye surgeries increases, the Excimer and Femtosecond Ophthalmic Lasers Market is experiencing significant growth and innovation.

The Excimer and Femtosecond Ophthalmic Lasers Market have witnessed notable advancements in laser technology, driving the improvement of vision correction procedures. With the development of wavefront-guided and topography-guided treatments, patients can achieve personalized and customized vision correction, addressing higher-order aberrations and irregularities. The integration of eye tracking systems enhances safety and precision, minimizing potential errors during laser surgeries. Moreover, femtosecond lasers have introduced new possibilities in corneal refractive surgeries and have been crucial in enabling bladeless and more predictable cataract surgeries. As technology continues to evolve, the market is poised for further expansion, offering enhanced outcomes for patients with various eye conditions.

Get a Sample Copy of the Report :https://www.futuremarketinsights.com/reports/sample/rep-gb-1717

The prevalence of refractive errors and eye disorders, such as myopia, hyperopia, astigmatism, and cataracts, is increasing worldwide, primarily due to factors like aging populations and lifestyle changes. As more individuals seek effective solutions to correct vision impairments and maintain ocular health, the demand for Excimer and Femtosecond Ophthalmic Lasers is on the rise. These lasers offer precise, safe, and minimally invasive procedures, making them a preferred choice for both patients and ophthalmic surgeons. The ongoing research and development in the ophthalmic laser industry are directed towards enhancing treatment options and addressing a broader range of eye conditions, further bolstering the market growth.

The global Excimer and Femtosecond Ophthalmic Lasers Market was worth US$ 1.02 billion in 2021, and it is expected to be worth US$ 1.18 billion by the end of 2022. Furthermore, with the rising prevalence of eye diseases worldwide and the increasing adoption of ophthalmic lasers, overall sales of excimer and femtosecond ophthalmic lasers are expected to rise at an 8.0% CAGR from 2022 to 2032, reaching a market valuation of US$ 2.41 billion by 2032.

The growth in the global excimer and femtosecond ophthalmic lasers market is attributed to the increasing prevalence of eye diseases across the world and the surging adoption of ophthalmic lasers, the overall sales of excimer and femtosecond ophthalmic lasers are projected to rise.

An excimer laser is known as a form of ultraviolet laser which is commonly utilized in ophthalmic surgeries. Excimer laser photorefractive keratectomy and excimer laser in-situ keratomileusis (LASIK) are some of the most common procedures conducted using a laser which is used to rectify refractive errors of the eye, as excimer laser alters the refractive state of the eye by removing tissue from the anterior cornea.

On the basis of application, the refractive surgeries segment dominated the global Excimer and Femtosecond Ophthalmic Lasers Market with a total value share of nearly 69% in 2021.

The excimer and femtosecond ophthalmic lasers are prominently used in surgical care for treating numerous eye disorders on account of their safe, precise, and accurate nature. Attributing to such attractive benefits and technological advancements, excimer and femtosecond ophthalmic lasers have the potential to become the gold standard of eye surgeries.

The increasing prevalence of multiple eye disorders such as glaucoma, macular degeneration, and diabetic retinopathy along with a surge in the number of eye surgeries performed worldwide is expected to bolster the growth of the Excimer and Femtosecond Ophthalmic Lasers Market during the assessment period.

Key Takeaways

An increase in the opening of ophthalmology clinics and hospitals in many nations all over the world is expected to propel growth in the market. Due to the rise in the number of elderly people visiting ophthalmology clinics and hospitals as well as the large numbers of diabetic people who have eye disease or are at risk of developing it. These aforementioned factors are anticipated to grow femtosecond and excimer ophthalmic laser market growth during the next ten years.
The government and several other regulatory bodies are meticulously working in order to make eye care services a crucial part of universal health coverage and address the increasing impact of vision loss on sustainable development. This is expected to create lucrative growth prospects within the global excimer and femtosecond laser market.
In order to provide ophthalmologists with some of the best equipment possible to efficiently perform delicate eye procedures, ophthalmic laser manufacturers are constantly improving their laser systems.
In comparison to manual surgery, Femtosecond laser cutting is done with greater precision and accuracy. Growth in the global excimer & femtosecond ophthalmic lasers market is mainly driven by the increasing diabetic and aging population globally. This increase is resulting in a rise in the number of common ophthalmic disorders such as cataracts, glaucoma, etc.
The surge in the prevalence of age-related macular degeneration (AMD), glaucoma, cataract, diabetic retinopathy, and presbyopia require surgical correction to restore normal vision. Therefore, the increased aging and diabetic population is a major factor expected to fuel the growth of the global Excimer and Femtosecond Ophthalmic Lasers Market over the forecast period.

Request Report Methodology:https://www.futuremarketinsights.com/request-report-methodology/rep-gb-1717

Competitive Landscape

The prominent market players in the healthcare sector are utilizing FLACS, or femtosecond laser-aided cataract surgery, as a safe and efficient therapy option for elderly patients, which is rapidly gaining ground. Hand-held surgical instruments in several procedures such as cataract fragmentation, anterior capsulotomy, and corneal incision are being drastically replaced by more efficient lasers resulting in increased accuracy and precision.

Key Companies Profiled: –

Medtronic Public Limited Company, Boston Scientific Corp, St Jude Medical LLC and Nevro Corp, Nuvectra Corporation and Stimwave, Neurosigma Inc., Synapse Biomedical Inc., Abbott Laboratories, Beijing PINS Medical Co., Ltd, Cirtec Medical Corporation, Gimer Medical, Bluewind Medical, Bioinduction, Greatbatch, Inc., Saluda Medical Pty Ltd.

Excimer and Femtosecond Ophthalmic Lasers Market Segments

Product:

Excimer Laser
Femtosecond Laser

Application:

Refractive Surgery
Cataract Surgery
Capsulotomy
Trabeculoplasty
Diagnosis

End User:

Hospitals
Ambulatory Surgical Centers
Ophthalmology Clinics

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Liquid Biopsy Market Poised to Surge Beyond US$ 4,126 Million by 2032, Redefining Cancer Detection and Monitoring

By 2023, the liquid biopsy market sales is expected to bring in US$ 1,538.3 million in revenue worldwide. Our healthcare domain experts predict that liquid biopsy providers will see robust growth, with a projected $10,938.6 million in sales by 2033 and a compound annual growth rate of 21.7% until that year.

One of the key factors driving the rapid growth of the Liquid Biopsy Market is its numerous advantages over conventional biopsy methods. Liquid biopsy offers minimal discomfort for patients, as it eliminates the need for surgical procedures, reducing the associated risks and complications. Additionally, it enables real-time monitoring of cancer progression and treatment response, allowing oncologists to make informed decisions on therapeutic strategies and adjust treatments accordingly. The versatility of liquid biopsy extends beyond cancer detection, with potential applications in prenatal testing, infectious disease monitoring, and personalized medicine. Its non-invasive nature and ability to capture tumor heterogeneity make it an indispensable tool in the modern oncology toolkit.

Get a Sample Copy of the Report :
https://www.futuremarketinsights.com/reports/sample/rep-gb-1396

The global liquid biopsy market is expected to be worth US$ 1,146 million in 2022, with a CAGR of 13.49% to reach US$ 4,126 million from 2022 to 2032. Cancer incidences are on the rise, and treatment rates are low.

A liquid biopsy is known to be a non-invasive procedure as compared to surgical biopsies which aid in discovering a tumor with the help of a simple blood sample. Traces of cancer’s DNA in the blood can help in giving clues about which treatments are most likely to work for that patient. Liquid biopsies are commonly used to diagnose non-small cell lung cancer (NSCLC) and screening or a companion diagnostic for numerous other types of cancers such as gastrointestinal, colorectal, breast, prostate, and ovarian cancer.

The Cost-effectiveness and high efficacy of liquid biopsy over several other diagnostic tests are chief factors responsible for market growth. Fast-track approvals from regulatory bodies such as the U.S. Food and Drug Administration (FDA) for non-invasive cancer diagnosis tests will continue creating growth opportunities.

Key Takeaways :

For decades, cancer has been constantly affecting humanity and the numbers continue to surge even with the emergence of better treatment and care. According to the reports by the World Health Organization (WHO), In 2020 it reported around 10 million deaths caused due to cancer. This staggering rise in number emphasizes the need for accurate and convenient cancer diagnostic systems for early detection.
Governments in several high cancer-burden nations have made a pledge to assist cancer research by offering them adequate funds that can aid in improved outcomes. For instance, as per the National Institute of Health (NIH), the federal government has allocated US$ 119 Million to National Cancer Institute for the fiscal year 2021.
The India-UK Cancer Research Initiative in 2018, focused on improved and affordable approaches to cancer diagnosis and treatment. This initiative received investments valued at £5 Million from the Department of Biotechnology (DBT), Ministry of Science & Technology, India, and Cancer Research UK (CRUK) each over a 5-year program.
The government-led initiatives are expected to further promote cancer specialists all over the world in order to set research goals aimed at affordability, convenience, and optimal patient care in cancer treatments. Adequate funding will allow experts to develop research alliances to enable significant improvements against numerous cancer outcomes.

Request Report Methodology:https://www.futuremarketinsights.com/request-report-methodology/rep-gb-1396

Competitive Landscape :

Key players in the liquid biopsy market are focusing on strategic collaborations with several end-users including hospitals, diagnostic centers, and cancer research institutes to strengthen their product offerings in the market. As per FMI analysis, tier-1 players will account for approximately 20-25% of the total sales.

Prominent industrial research funding along with product development agreements will offer proprietary benefits to manufacturers, helping them contribute to the development of accurate diagnosis methods for various cancers. In addition, gaining patents and government approvals for new technologies will remain one of the prominent growth strategies.

More Insights into the Liquid Biopsy Market

According to the FMI analysis, the U.S. is anticipated to account for around 51% of the total market share in the global liquid biopsy market during the projection period. Growth prospects in the U.S. are attributed to surging government funding in order to support cancer research. The rising prevalence of cancer across the U.S. will generate high demand for highly accurate liquid biopsy services. Widespread technological developments including artificial intelligence, machine learning, and microchip-based liquid biopsy diagnostic services will lead to market expansion in the U.S.

The European liquid biopsy market is anticipated to surge significantly throughout the forecast period, attributed to the desirable healthcare policies along with high average per capita healthcare costs, which have produced a favorable climate in the United Kingdom for the adoption of modern cancer diagnostic technology.

The technological developments in the U.K. are expected to offer lucrative growth opportunities for players operating in the market, allowing them to benefit from technological advancements for better products and services. The U.K. will account for 24% of the market share, as estimated by FMI.

According to the FMI market survey, government initiatives in emerging economies like India are aimed at improving cancer awareness, research, and development and are anticipated to propel the growth of the liquid biopsy market in India, as per FMI’s market survey. As revealed by the National Cancer Registry, cancer incidence in men is estimated to reach 736,575 in 2025, with 806,218 cases to be recorded in women.

Key Segments Profiled in the Liquid Biopsy Industry Survey

Liquid Biopsy Market by Marker Type:

CTCs (Circulating Tumour Cells)
ctNA (Circulating tumor Nucleic Acids)
Exosomes

Liquid Biopsy Market by Sample Type:

Blood Liquid Biopsy
Urine Liquid Biopsy
Others (Plasma, Saliva, CSF) Liquid Biopsy

Liquid Biopsy Market by Application Type:

Liquid Biopsy for Lung Cancer
Liquid Biopsy for Gastrointestinal Cancer
Liquid Biopsy for Prostate Cancer
Liquid Biopsy for Breast Cancer
Liquid Biopsy for Colorectal Cancer
Liquid Biopsy for Leukemia

Liquid Biopsy Market by Region:

North America Liquid Biopsy Market
Latin America Liquid Biopsy Market
Western Europe Liquid Biopsy Market
Eastern Europe Liquid Biopsy Market
APEJ Liquid Biopsy Market
Japan Liquid Biopsy Market
Middle East and Africa Liquid Biopsy Market

Author By:

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

“Empowering Aging Gracefully: The Surge in Demand for Older Adults Health Supplements Driving a US$ 265 Billion Market by 2032

In order to attain a valuation of US$ 265 billion by 2032, the market for Older Adults Health Supplements Market i for older persons is expected to grow at a compound annual growth rate (CAGR) of 6% from US$ 140 billion in 2021 to US$ 265 billion.

Increased health consciousness and an ageing population are driving growth in the older adults health supplements market. It addresses health concerns associated with ageing and sees a surge in demand for supplements that support joint health, brain function, and general vitality. It is expected that ongoing research and product developments would support its expansion.

Supplements to the diet or health comprise a wide range of goods that are primarily taken to improve health and balance the diet. The market for health supplements targeted towards older persons is witnessing a significant change in growth as the global population continues to rise, including an increase in the number of elderly people.

It has been noted that the body’s ability to absorb certain essential nutrients declines with age. As a result, essential nutrients must be supplied externally through the use of health supplements for seniors. It is projected that the market for supplements for older adults’ health would undergo a significant shift due to the rise in its consumption among the cognizant aged.

Unlock the Power of Knowledge Download our Report Sample now and expand your understanding @
https://www.futuremarketinsights.com/reports/sample/rep-gb-10008

These supplements serve as beneficial alternatives to combat the deficiency of key nutrients in older adults population. They are available in different forms such as pills, liquids, powdered supplements, energy bars and others.

The Increase in Healthcare Awareness Drives the Demand for Older Adults Health Supplements

The increase in awareness of healthcare is anticipated to serve as the major driver for older adults health supplements market. The elderly population constitutes a massive number of the total population in the world. According to United Nations report, the population aged 60 years or above numbered 962 million in the year 2017.

Since the elderly these days are more aware about various diseases such as cardiovascular diseases, sore joints, memory loss, loss of vision and others that may happen in the old age, they are switching to these older adults health supplements. Also, a shift in fitness trends serves as a huge driver and opens more opportunities for the growth of the older adults health supplements market because the elderly these days are aware of physical and mental fitness and inquisitive and keen to invest their money in older adults health supplements that can help them to cut down the healthcare costs and aid in keeping them fit and healthy.

The Older adults health supplements can nowadays be found easily in the supermarkets, hypermarkets and others as the trend in the consumption of these supplements is increasing so, increase in healthcare awareness, urbanization, change in the fitness trends and advancement in living standards is impacting the older adults health supplements Market positively.

Older Adults Health Supplements: Key Participants

Bayer AG
Pharma Nord Inc.,
Epax Norway AS
Validus Pharmaceuticals
Lexicare Pharma Private Limited
Biocare Copenhagen A/S
Bright Food (Group) Co., Ltd
Otsuka Pharmaceutical Co.,Ltd.
Healthy life Pharma Private Limited
SNU Biocare
Saipro Biotech Private Limited.
V.R.Industries Pvt. Ltd
Nutra Helthcare

The research report presents a comprehensive assessment of the Older adults health supplements Market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies.

Take control of your decisions Unlock the power of data with a custom report Ask now@
https://www.futuremarketinsights.com/customization-available/rep-gb-10008

Older Adults Health Supplements: Regional Analysis

The huge number of the elderly population and an increase in health and fitness trends is anticipated to serve as a driver for the increase in demand for older adults health supplements in the Asia Pacific region and North America. The rise in income and changing lifestyle are also a few drivers for the older adults health supplements market.

The majority of Americans and Japanese are now aware of the benefits that these older adults health supplements offer and are therefore including them in their diet. The amount of elderly population in the world is anticipated to grow with the growing population of the world which is estimated to increase the demand for older adults health supplements.

The report covers exhaustive analysis on:

Older adults health supplements market Segments
Market Dynamics
Market Size
Supply and Demand
Current Trends/Issues/Challenges pertaining to Older adults health supplements market
Competition Landscape and Emerging Market Participants in Older adults health supplements Market
Technology related to Production/Processing of Older adults health supplements Market
Value Chain Analysis of Older adults health supplements Market

The regional analysis includes:

North America (U.S., Canada)
Latin America (Mexico, Brazil)
Europe (Germany, U.K., France, Italy, Spain, Poland, Russia)
East Asia (China, Japan, South Korea)
South Asia (India, Thailand, Malaysia, Vietnam, Indonesia)
Oceania (Australia, New Zealand)
Middle East & Africa (GCC Countries, Turkey, Northern Africa, South Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators, and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on Older adults health supplements markets segments and geographies.

Don’t miss out on this golden opportunity Unlock detailed market intel now and stay ahead of the competition Purchase today@
https://www.futuremarketinsights.com/checkout/10008

Older Adults Health Supplements Market Segmentation

The Older adults health supplements Market can be segmented on the basis of Nature, Form, Flavors and Sales channel.

The Older adults health supplements Market can be segmented on the basis of Nature as:

Organic
Conventional

The older adults health supplements can be segmented on the basis of Form as:-

Pills
Powders
Liquids
Energy Bars

The Older adults health supplements Market can be segmented on the basis of Flavour as:

Orange
Lemon
Cherry
Raspberry
Chocolate
Strawberry

The Older adults health supplements Market can be segmented on the basis of Sales Channel as:

B2C
Stores Based Retailing
Grocery Retailers
Modern grocery retailers
Hyper Markets
Super Markets
Online Retailing

Report Highlights:

Detailed overview of parent market
Changing dynamics of the Older adults health supplements market in the industry
In-depth market segmentation and analysis
Historical, current, and projected market size in terms of volume and value
Recent industry trends and developments in the Older adults health supplements market
Competitive landscape of the Older adults health supplements market
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on Older adults health supplements market performance
Must-have information for Older adults health supplements market players to sustain and enhance their market footprint

About Future Market Insights (FMI)

Contact Us:

Antibodies Market Set for Exceptional Expansion, Aiming for US$ 834.2 Billion with a 13.4% CAGR by 2033

The antibodies market size is growing at a rapid pace due to the increasing use of monoclonal antibodies in research, medicines, and diagnostics. These incredibly adaptable and specialised compounds are now essential to the biotechnology and pharmaceutical industries. The market for antibodies is expected to increase steadily due to the increasing focus on targeted therapies and precision medicine. This presents a favourable prospect for businesses engaged in antibody production, research, and pharmaceuticals development.

From 2023 to 2033, the Antibodies Market is projected to grow at a CAGR of 13.4%, with a target market value of US$ 236.9 billion in 2023. The antibody market is projected to be worth US$ 834.2 billion by 2033. The absolute dollar growth of the global market, which amounts to US$ 597.3 billion, represents the total market value of the antibodies sector.

A renowned provider of market research and competitive data, Future Market Insights, predicts that by the end of 2031, the antibodies market will have grown by a factor of 21 and will be worth more than US$ 601.614 billion.

Hoffmann-La Roche Ltd., AbbVie Inc., Johnson & Johnson Services, Inc., Amgen Inc., and Bristol-Myers Squibb Company are among the market’s top competitors, according to FMI surveys. Three out of every four sales of antibodies worldwide are accounted for by these big players.

Get a Sample Copy of the Report:https://www.futuremarketinsights.com/reports/sample/rep-gb-1330

About 4% of the world’s population is afflicted by an autoimmune disease, according to reports from the National Stem Foundation (NSCF). Diabetes, MS, Crohn’s disease, and rheumatoid arthritis are the most prevalent autoimmune illnesses. The market for antibodies is predicted to be extremely in demand as a result of these chronic disorders.

Key Insights:

Antibodies are essential for treating medical conditions including autoimmune diseases, cancer, and several types of neurological diseases. Immunoglobulin (IG) is a type of antibody that is used for the prevention of lower respiratory tract infections and diseases caused by the vaccinia virus. Rising cases of viral infection will drive the demand for antibodies.

The prevalence of autoimmune diseases is on the rise, and they also have the potential to act as a host for multiple chronic ailments. Owing to these factors, the demand for antibodies is forecast to increase in upcoming years.

The COVID-19 pandemic boosted the demand for antibodies as patients suffering from COVID-19 were highly susceptible to contracting various other ailments and, in some cases, triggered autoimmune diseases in the patient.

Novel biosimilar antibody manufacturers are slashing their prices to compete with branded antibody manufacturers, especially in the European market. With the expiration of patents of renowned products, a boost in demand for biosimilar antibodies can be expected in upcoming years.

A reasonable hike in research and development activities among healthcare and pharmaceutical market leaders are working towards developing effective and economical antibodies and biosimilar antibodies, propelling growth in the market.

Parkinson’s and Sclerosis diseases are on the rise among older people which is a key factor fueling the demand for antibodies. There is an urgency to develop cheap and personalized medicines, novel and effective treatments, and advanced therapeutics in middle-income countries which is expected to positively influence the sales of antibodies.

The widespread application of antibodies in chronic disease treatment is accelerating which is predicted to create scope for market expansion in the near future.

Competitive Landscape:

Novartis AG, F. Hoffmann-La Roche AG, Johnson & Johnson, Takeda Pharmaceutical Company Limited, Amgen Inc., Biogen Inc., Bristol-Myers Squibb Company, AbbVie Inc., Sanofi SA, Eli Lilly, and Co. are some of the key companies profiled in the full version of the report.

Future Market Insights (FMI) has found that market players are working towards developing new antibodies to treat cancer and other diseases. They are also researching to create long-acting antibody drugs to reduce healthcare costs.

In order to gain a competitive edge in the antibodies market, key players are developing oral and noninvasive treatments using antibodies to treat chronic ailments. Strategic mergers and acquisitions for portfolio expansion are in the cards as well.

More Insights into Antibodies Market

The United States is considered the dominant market in the North American region owing to modern healthcare infrastructural facilities and the presence of leading market players in the country. An increase in government funding and elevated purchasing power is expected to drive growth in the market.

The GCC countries led by Saudi Arabia are increasingly focusing on research and development on early diagnosis and screening of cancer to elevate the survival rate and chance of successful treatment. The contribution of antibodies is significant in this research. Hence, propelling growth in the market.

The development and production of antibodies are on a rise in China and are expected to surge significantly owing to increasing government investment in drugs and development coupled with growing awareness about various medical ailments like rheumatoid arthritis, cancer, and infections.

The Indian antibodies market is anticipated to grow at a rapid pace owing to rising cases of cancer and cardiovascular diseases along with the development of the healthcare system in the country. According to the reports of the Global Cancer Observatory, 1.322 million new cancer cases were registered in India in 2020, while 2.72 million people had cancer for 5 years. A surge in cancer patients will drive the demand for monoclonal antibodies for cancer treatment.

Request Report Methodology:https://www.futuremarketinsights.com/request-report-methodology/rep-gb-1330

Key Segments Covered in Antibodies Market Study

By Disease Indication

Cardiovascular diseases
CNS disorders
Cancer
Autoimmune Disorders

By Product Type

Monoclonal antibodies
Polyclonal antibodies
Antibody-drug complexes (ADCs)

By End User

Hospitals
Long-term Care Facilities
Research institutes

Author By:

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

From Plant-Based Power Unveiling the Growth Trajectory of Algal Protein Market Projected to Surpass USD 1,010 Million by 2032

The global algal protein market is anticipated to create an absolute dollar opportunity by generating a revenue of US$ 700 Mn by the end of 2022. The sales of algal protein are expected to exceed US$ 1010 Mn by 2032, projecting growth at a robust CAGR of nearly 8% to 9% during the forecast period 2022-2032. There is a massive consumer shift seen in the market from adopting animal-based proteins to plant-based protein alternatives is estimated to augment the demand for algal protein.

Algae is known as an abundant form of plant life that contains chlorophyll, found in both freshwaters and marines as well. Algal protein is the protein derived from algae, ranging from single-cell microalgae to large seaweeds. The protein derived from different algae, such as microalgae and seaweed, contains high protein levels.

Read our sample report to learn more about the results of greater investment in the port wine industry :
https://www.futuremarketinsights.com/reports/sample/rep-gb-4502

The algal proteins are commonly extracted from specific types of algae such as blue algae, green algae, and red algae which has the ability to be processed into various forms including pastes, liquids, powder, and capsules. Algae living in marine waters contain approximately 60% of protein of their weight, which is way higher in comparison to algae living in freshwater.

Key Takeaways

Some algae such as chlorella and spirulina compose high protein content and other freshwater algal proteins that are majorly derived from spirulina are one of the richest sources of protein containing all essential minerals, amino acids, and carotenoids. Therefore, increasing consumption of algal proteins, owing to the growing awareness regarding their health benefits is estimated to bolster sales in the global market.
Algal proteins that are extracted from freshwater and marine water are gaining massive popularity among industries such as food & beverage, cosmetics, and animal feed owing to their excellent nutritional capabilities, amino acid profile, cell damage repairing properties, and others.
There is a wide range of application of these proteins across the nutrition and supplement sectors, as consumption of algal proteins assist in boosting the immune system, reducing fatigue, improving digestion, building endurance, and boosting energy levels. Owing to these numerous health benefits, algal proteins are gaining traction amongst athletes, sportspersons, bodybuilders, and others, thereby, facilitating the growth in the market.
A swift inclination towards veganism and vegetarianism is also being witnessed across the globe, resulting in the rising awareness concerning physical health, animal welfare, and ethical reasons. This significant rise in the vegan and vegetarian population is estimated to accelerate the sales of plant-based proteins such as algal proteins, thereby, bolstering the growth in the global market.

Get the Finest Selections from the Top Premium Port Wine Producers Right Now to Experience the Rich Flavours and Traditions of the World:
https://www.futuremarketinsights.com/checkout/15123

Competitive Landscape

Far East Microalgae Industries, Co., Ltd., Bio-engineering Co., Ltd., Tianjin Norland Biotech Co., Ltd., Prolgae, NB Laboratories, Cyanotech Corporation, C.B.N., Gong Bih Enterprise Co., Ltd., Taiwan Chlorella Manufacturing Company Ltd, Algenol Biotech, Fuqing King Dnarmsa Spirulina Co., Ltd., Sun Chlorella Corporation are some of the key companies profiled in the full version of the report.

Leading players are aiming at launching new products and expanding their production capacity to gain an edge in the highly competitive market. Key supplement manufacturers are increasingly emphasizing launching novel plant-based protein products to capitalize on the existing opportunities.

More Insights into the Algal Protein Market

The North American region is anticipated to dominate the global algal protein market by accounting for the maximum market share between 2022 and 2032, states Future Market Insights.

Countries including Canada and the U.S. are witnessing a significant rise in the burden of diseases such as thrombosis, atherosclerosis, cancers, and arthritis, creating strong demand for preventive supplements.

According to a study conducted by the American Cancer Society, nearly 1.9 million new cases of cancers were estimated to be diagnosed across the U.S., causing around 608,570 fatalities in the year 2021. The surge in such lethal diseases has led to a significant rise in the demand for algal protein in the global market.

Algal protein is increasingly being prescribed for the prevention of chronic diseases as it contains omega-3 fatty acids and carotenoids which assist in enhancing the immune system, improving cardiovascular function, and reducing allergies & inflammation within the body. Thus, the growing prevalence of such diseases is projected to augment the demand for algal protein in the North American market.

According to FMI analysis, the Asia Pacific region is anticipated to project rapid growth in the global algal protein market during the forecast period 2022-2032.

Owing to the rising population of vegetarian and vegan people due to its increased health benefits, the demand for plant-based proteins is surging at a rapid pace.

Key Segments Profiled in the Algal Protein Market

By Product Form:

Powder
Liquid

By Product Source:

Marine Algae
Fresh Water Algae

By Type:

Spirulina
Chlorella

By Application:

Dietary Supplements
Food & Beverage
Animal Feed
Cosmetics
Others

By Region:

North America
Latin America
Western Europe
Eastern Europe
South Asia and Pacific
East Asia
Middle East and Africa

About Future Market Insights (FMI)

Contact Us:

Milk Powder Packaging Market Impact: Sustainable Solutions

Milk powder packaging refers to the packaging solutions used for storing and transporting powdered milk products. These packaging materials are designed to protect the milk powder from moisture, light, air, and other external factors that could compromise its quality and shelf life.

The Milk Powder Packaging Market is poised for steady growth, with projections indicating a Compound Annual Growth Rate (CAGR) of approximately 4% during the forecast period spanning from 2021 to 2031. A primary catalyst driving this growth is the emphasis on effective marketing strategies and product safety measures, which contribute to increased revenue generation within the milk powder packaging market.

Packaging plays a pivotal role in enhancing the perceived value of milk powder among consumers. By offering stability and visually appealing packaging, manufacturers can elevate the perceived quality of the product, instilling confidence in consumers regarding its taste, nutritional content, hygiene, and safety. This assurance is instrumental in fostering consumer trust and loyalty, ultimately translating into heightened demand and sales for milk powder products.

Get Exclusive Sample Copy of the Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-13556

Furthermore, packaging serves as a powerful tool for marketing and promotion, acting as the first point of contact between the product and the consumer. Through innovative and eye-catching packaging designs, manufacturers can effectively communicate the unique selling propositions of their milk powder products, differentiate them from competitors, and capture the attention of target consumers. Additionally, packaging serves as a means of conveying essential product information, such as nutritional content, usage instructions, and safety warnings, further enhancing consumer engagement and satisfaction.

Growth Factors

With the increasing popularity of powdered foods worldwide, the demand for milk powder packaging has experienced consistent growth. This trend is expected to directly influence the global demand for milk powder packaging as consumers continue to seek convenient and shelf-stable options for dairy products.

Effective packaging of milk powder is essential as it significantly impacts the safety, marketing, and overall quality of the product. Milk powder, with its inherent fat content and hygroscopic nature, is prone to lipid oxidation and moisture absorption. Therefore, proper packaging is imperative to protect the product from exposure to oxygen, light, contaminants, and moisture, which can compromise its freshness, flavor, and nutritional integrity.

By employing appropriate packaging materials and techniques, manufacturers can safeguard the quality and safety of milk powder products throughout the supply chain, from production to consumption. This includes utilizing barrier films, laminates, and hermetic seals to create a protective barrier against external factors that could degrade the product. Additionally, opaque or UV-resistant packaging helps shield milk powder from light-induced degradation, ensuring product stability and shelf life.

Key features and considerations for milk powder packaging include:

Barrier Properties: Milk powder packaging must provide an effective barrier against moisture and oxygen to prevent spoilage and maintain the freshness of the product. Materials such as laminated films, aluminum foil, and high-barrier plastics are commonly used to achieve this barrier function.
Protection from Light: Exposure to light can degrade the quality of milk powder by causing oxidation and off-flavors. Therefore, milk powder packaging often incorporates opaque or light-blocking materials to shield the product from harmful UV rays.
Seal Integrity: Proper sealing is crucial for preventing contamination and moisture ingress. Milk powder packaging may feature heat-sealed seams, zip-lock closures, or other secure sealing mechanisms to ensure the integrity of the package until it is opened by the consumer.
Packaging Formats: Milk powder packaging is available in various formats, including pouches, sachets, cans, jars, and bulk bags. The choice of packaging format depends on factors such as consumer convenience, shelf life requirements, and marketing considerations.

Request Report Methodology: https://www.futuremarketinsights.com/request-report-methodology/rep-gb-13556

Key Players

Nichrome Packaging Solutions
Hassia Redatron
Tetra Pak
Arla Foods
Arodo
Others.

Key Segments

By Type:

Tins
Flexible pouches
Others

By Region:

North America
- US
- Canada
Latin America
- Brazil
- Mexico
- Rest of Latin America
Europe
- UK
- France
- Germany
- Italy
- Spain
- BENELUX
- Russia
- Rest of Europe
East Asia
- China
- Japan
- South Korea
South Asia & Pacific
- India
- Thailand
- Indonesia
- Malaysia
- Australia & New Zealand
- Rest of South Asia & Pacific
Middle East & Africa
- GCC Countries
- Turkey
- South Africa
- Rest of Middle East and Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer, Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Veterinary Vaccines Market Gallops Towards Exceeding a Noteworthy US$ 20.82 Billion by 2033, Fueled by Growing Animal Health Awareness

The veterinary vaccines market sales is predicted to have expanded from US$ 11.3 billion in 2023 to over US$ 20.82 billion by 2033. This is expected to generate a compound annual growth rate (CAGR) of 6.2% from 2023 to 2033 and further increase the market share of veterinary vaccinations.

The increasing awareness among pet owners, livestock farmers, and veterinarians about the significance of animal health has been a key driver for the Veterinary Vaccines Market. Governments and regulatory bodies worldwide have also recognized the importance of disease prevention in animals to ensure public health and food safety. This heightened focus on animal health has led to a surge in research and development activities, aiming to create innovative and more effective veterinary vaccines. Moreover, the shift from reactive to proactive veterinary care has further accelerated the adoption of vaccination programs, driving market growth.

Get a Sample Copy of the Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-409

In recent years, significant advancements in biotechnology and vaccine development have revolutionized the Veterinary Vaccines Market. Novel vaccine platforms, such as recombinant vaccines and vectored vaccines, offer improved efficacy and safety profiles, providing veterinarians and animal owners with a broader range of preventive options. Additionally, advancements in adjuvant technologies and formulation techniques have enhanced vaccine stability and immune response, contributing to the success of vaccination campaigns and disease control efforts. The continuous progress in vaccine technology promises to bring forth even more innovative solutions to address emerging infectious challenges in the veterinary sector.

With the increasing occurrence of zoonotic diseases (diseases that can be transmitted from animals to humans) in recent times, the role of veterinary vaccines in preventing zoonotic infections has gained paramount importance. Diseases like rabies, avian influenza, and brucellosis pose significant threats to both animal and human populations. By immunizing animals against zoonotic agents, veterinary vaccines act as a crucial barrier in breaking the transmission cycle and safeguarding public health. Governments and international organizations have been actively promoting zoonotic disease prevention through comprehensive vaccination programs, further fueling the demand for veterinary vaccines.

The Veterinary Vaccines Market has witnessed notable growth in developing regions, attributed to several factors. Rising livestock production, increasing pet ownership, and growing awareness of animal health in these regions have contributed to market expansion. Additionally, collaborations between international vaccine manufacturers and local players have facilitated the transfer of technology and expertise, further boosting vaccine accessibility and affordability. As these regions continue to experience economic growth and urbanization, the demand for quality veterinary vaccines is projected to surge, presenting new opportunities for market players.

The net worth of the veterinary vaccine market share is expected to rise from US$ 11.3 billion in 2023 to more than US$ 20.82 billion by 2033. This is expected to increase veterinary vaccine market share and register a CAGR of 6.2% between 2023 and 2033.

The global veterinary vaccines market is expected to grow at a healthy 7.2% CAGR between 2022 and 2026. The global market was expected to grow at a 6.5% YoY rate in 2021, with the global veterinary vaccines market valued at around US$ 10 billion. By 2026, the market is expected to be valued at more than US$ 14.1 billion.

The growth of the global veterinary vaccines market is expected to surge amid the increasing prevalence of animal diseases all over the world. Sales of veterinary vaccines accounted for around 91.3% share of the global veterinary biologics market in 2021. Based on product, the attenuated live vaccines segment leads the veterinary vaccines market with nearly ¼ market share.

As the threat of another pandemic bestows over the world, improving animal health is one of the major priorities for people and governments all over the world. On an annual basis, billions of dollars are being spent on pharmaceuticals and vaccines to protect animals from a wide range of diseases as well as to improve their immunity. This is expected to generate growth prospects for veterinary vaccine suppliers and manufacturers during the forecast period. Surging efforts to develop vaccines for zoonotic diseases which are also commonly found in humans as well is set to improve the growth of the overall veterinary vaccines market.

Veterinary vaccines have rapidly become ideal preventive healthcare solutions in order to protect animals from developing and contracting lethal diseases as well as for improving their immunity systems. These vaccines allow pet owners and farmers to significantly reduce the spread of infectious diseases, improve their pet’s health and minimize healthcare costs. The variation between the BPS values observed within the global veterinary vaccines market in H1, 2022 – outlook over the H1, 2022 projected period reflects a decline of 20 BPS units. Furthermore, a decline in BPS growth in H1-2022 over H1-2021 by 13 Basis Point Share (BPS) is demonstrated by the market.

Key Takeaways:

The global veterinary vaccines market is gaining traction over the projection period due to the rising prevalence of zoonotic diseases, surging demand for animal products, and growing trend of pet adoption across the world. Among some of the key driving factors of the global veterinary vaccines market is the exponential growth of the animal healthcare products market.
The rapid expansion of the veterinary respiratory disease treatment market along with the veterinary pain management drugs market attributed to the increasing spending by pet owners on improving the health of their pets will create sales prospects for veterinary vaccines throughout the forecast period.
Massive popularity can be seen within the veterinary vaccines market for their potential to protect animal health along with public health as they effectively mimic naturally acquired immunity. Among the developing nations, veterinary vaccine sales are estimated to be high owing to the increasing pet ownership. These vaccines play a crucial role in assuring longevity and good health in animals.
The introduction of technologically advanced vaccinations, increasing livestock population, rising government investments and initiatives to tackle the burden of animal diseases, and expanding pet care market across developing regions are anticipated to create growth avenues within the global veterinary vaccines market during the forthcoming years.
The rapid surge in the animal healthcare market combined with the companion animal vaccines market is anticipated to generate lucrative prospects for the manufacturers of veterinary vaccines during the forecast period between 2022 and 2026.

Competitive Landscape:

Key players profiled in the global veterinary vaccines market are focusing on continuous investments in research and development activities for the introduction of effective vaccines. Besides this, leading veterinary vaccine manufacturers are adopting various market strategies such as joint ventures, collaborations, partnership agreements, sales agreements, and capacity expansion to expand their global footprint.

Request Report Methodology:https://www.futuremarketinsights.com/request-report-methodology/rep-gb-409

More Insights into the Veterinary Vaccines Market

The U.S. is anticipated to be a dominant market for veterinary vaccines attributing to the surging frequency of drug approvals, advances in veterinary science, rise in pet adoption rate, and the emergence of new veterinary vaccine market trends.

China is yet another country emerging as an opportunistic market for veterinary vaccines, combined by collaborative initiatives of governments and private firms in order to promote better animal healthcare with advanced veterinary medical devices.

Key Companies:

Boehringer Ingelheim GmbH,
Zoetis Inc.
Elanco Animal Health,
Merck & Co., Inc.
Bayer AG
Virbac Group
Ceva Santé Animale
Phibro Animal Health Corporation
Others

Veterinary Vaccines Market Segmentation by Category

By Product:

Attenuated Live Vaccines
Conjugate Vaccines
Inactivated Vaccines
Subunit Vaccines
Toxoid Vaccines
DNA Vaccines
Recombinant Vaccines

By Disease:

Anaplasmosis
Canine Parvovirus
Foot & Mouth Disease
New Castle Disease
Distemper Disease
Influenza
Porcine Reproductive & Respiratory Syndrome (PRRS)
Others

By Distribution Channel:

Veterinary Clinics
Veterinary Hospitals
Veterinary Research Institutes
Retail Pharmacies

By Species:

Companion Animals
- Canine
- Avian
- Feline
Livestock Animals
- Aquatic
- Bovine
- Porcine
- Ovine/Caprine
- Poultry
Equine

Author By:

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Fertility and Pregnancy Rapid Test Kit Market Braces for Remarkable Expansion, Targeting US$ 1,609.1 Million Valuation by 2033

Fertility and Pregnancy Rapid Test Kit Market Sales are expected to rise in 2022, reaching a peak of US$ 1.34 billion by the end of the year, according to Future Market Insights. An award-winning research firm recently issued a paper examining statistics on the global rise in rates of gynaecological problems over the previous 10 years, including fibroids, uterine polyps, polycystic ovarian syndrome, and unexplained infertility.

A three layered data of rapid pregnancy fertility test kits penetration across different channel and average monthly sales has been collected and global market statistics has been calibrated.

Consumer spending on self-diagnosis has increase by two fold in last three year, which is subjected to high associated and recurring cost for opting services from professional pathology labs. Raid test kits is convenient and comes with low complexity which captivate potential customers.

The report provides detail on other associated factors that has propelled the demand for these kits. One of such factor include the widespread availability of fertility and pregnancy rapid test kits on online sales channel as well its categorization as OTC product.

Get a Sample Copy of the Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-607

Dual Capability Tests To boost The Sales of Fertility And Pregnancy Rapid Test Kits

Manufacturers are providing pregnancy test kits with dual capability and are also offering combined packs of fertility and pregnancy rapid tests, which can be used to qualitatively detect the presence of HCG hormone in both – urine and serum/blood. Users are rapidly adopting these combo kits as this eliminates the necessity to buy separate kits for urine and blood/serum testing. For instance, various products such as QuickVue HCG Combo, Test & Confirm, ICON 25 HCG, and many others are available commercially; which prove to be cost-effective. Covid-19 is adding to the sales of home-made combo kits; as social distancing forbids them from visiting the labs for tests.

Key Takeaways of Fertility and Pregnancy Rapid Test Market Study

Among distribution channels segmentation, pharmacies and drug stores are expected to hold nearly 50% of the market share
Rising age of first time pregnancy in North America is one of the major factors that drive its growth to the leading position in the market.

“Considering the rising adoption of fertility and pregnancy rapid testing kits, online sales platforms and OTC arms of the companies offer sizable opportunities for potential global market growth.” says the FMI analyst

Collaborations with e-Commerce Partners – A Key Strategy

The market for fertility and pregnancy test kits is rapidly growing and key players are looking for strategic options to expand globally. While most players have a fairly good distribution network locally as well as globally, the strong competition presses these players to look for options to reach out to more number of customers to sustain in the market.

Most companies focus on sales of fertility and pregnancy test kits through online sales channels. With products available online, buyers can choose from a wide variety of products to best suit their requirements. For instance many e-commerce portals such as Walmart, Amazon Inc., etc. offer variety of brands with discounted prices which attract the buyer.

Church & Dwight Co. Ltd., a major company in pregnancy and fertility test market generated 24% share of total revenue from sale of products through online distribution partner WalMart. PharmEasy is amongst the online pharmacy stores who delivers medicines to 98% PIN codes in India.

Request Report Methodology:https://www.futuremarketinsights.com/request-report-methodology/rep-gb-607

Key Players :

Alere Inc.
Quidel Corporation
Prestige Brands Holdings, Inc.
Church & Dwight Co., Inc.
bioMérieux SA
Geratherm Medical AG
Abbott Laboratories
Procter & Gamble Co.
DCC Plc.
Swiss Precision Diagnostics GmbH

Fertility And Pregnancy Rapid Test Kits Market By Category By Product :

Pregnancy Rapid Tests
- Line-Indicator devices
  - Strips/Dip Sticks
  - Mid-Stream
  - Cassettes
- Digital
Fertility Rapid Tests
- Line-Indicator
- Digital

By Test Type :

LH Urine
FSH Urine
hCG Blood
hCG Urine

By Distribution channel :

Pharmacy
Drugstore
Gynecology/Fertility Clinics
e-commerce
Hypermarkets & Supermarkets

By Region :

North America
Latin America
Western Europe
Eastern Europe
APEJ
MEA
Japan

Author By:

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Arthroscopy Procedure and Products Market Ascends on a Skyward Trajectory, Anticipating a 7.1% CAGR Through 2033

In 2023, the arthroscopy procedures and products market trends related to arthroscopy is projected to be valued US$6,860.8 million.

Osteoarthritis (OA) is becoming more common in older people, and this is driving the market revenue, which is expected to grow at a compound annual growth rate (CAGR) of more than 6.2% between 2023 and 2033.

Due to the ageing population’s growing predilection for arthroscopic procedures, particularly in the US and Germany, growth is still strong throughout North America and Europe. Together, North America and Europe make up more than 77% of the world’s revenue.

Get a Sample Copy of the Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-1386

Key Takeaways:

In terms of procedure type, knee arthroscopy will account for over 50% of the global market share
Arthroscopic implants segment will account for highest share of the arthroscopy procedures & products market during the forecast period
The U.S. will emerge as the most lucrative market backed by the rising prevalence of degenerative disease among the geriatric population
Germany and the U.K., collectively, will emerge as the most lucrative market across Europe in the upcoming decade
Japan is anticipated to emerge as a lucrative market backed by the high prevalence of rheumatoid arthritis and osteoarthritis among elderly

“Increasing prevalence of osteoarthritis and growing degenerative disease among elderly population have encouraged the leading players to engage in research & development activities to develop advanced procedure & instrument for non-invasive surgeries,” says the FMI analyst.

The prevalence of knee osteoarthritis in the senior population is rising, and there are more knee arthroscopies being performed globally, which has boosted market growth. Growth is being fueled by expanding applications in sports medicine and simple regulatory approval processes like those used by the US Food & Drug Administration.

Patients with severe osteoarthritis are favouring knee arthroscopy because to its non-invasiveness and benefits, which is propelling market growth.

The adoption of knee arthroscopy surgeries in the U.S., Germany, the UK, and China has been prompted by the rising prevalence of osteoarthritis in those countries.

Healthcare professionals and the government are expanding their efforts to provide rehabilitation and amenities in order to reduce the additional expense in light of the rising figures. Based on these variables, the market is expected to expand at a rate of over 7.7% CAGR between 2021 and 2031.

The market’s expansion could be hampered by the rising danger of edoema and other illnesses such blood clots in the joints. Additionally, high surgical and treatment costs in developing nations like Brazil, India, and other Latin American nations would restrain market expansion.

Key Takeaways:

In terms of procedure type, knee arthroscopy will account for over 50% of the global market share
Arthroscopic implants segment will account for highest share of the arthroscopy procedures & products market during the forecast period
The U.S. will emerge as the most lucrative market backed by the rising prevalence of degenerative disease among geriatric population
Germany and the U.K., collectively, will emerge as the most lucrative market across Europe in the upcoming decade
Japan is anticipated to emerge as a lucrative market backed by the high prevalence of rheumatoid arthritis and osteoarthritis among elderly

“Increasing prevalence of osteoarthritis and growing degenerative disease among elderly population have encouraged the leading players to engage in research & development activities to develop advanced procedure & instrument for non-invasive surgeries,” says the FMI analyst.

Competitive Landscape:

Prominent players in the market are focusing on strategic mergers and collaboration to expand their global footprint in the market.

New product launches coupled with increasing research & development activities for the development of advanced arthroscopy instruments & devices will also be one of the key strategy to enhance their customer base for market players.

For instance, couple of years back, leading player, Smith & Nephew entered into a distribution agreement with OrthAlign, a U.S. based private company to develop medical devices and distribute their Total-Knee Arthroplasty (TKA) technology across several countries in Africa and Middle East.

Also, in 2018, Ceterix® Orthopedics, Inc., a leader in the development of cutting-edge surgical tools for orthopedic surgeons announced the U.S. Food and Drug Administration (FDA) 510(k) clearance of NovoStitch® Pro Meniscal Repair System – a size 0 suture cartridge – offering surgeons more options to repair meniscal tears for arthroscopic surgeries.

Key Companies:

Arthrex Inc.
CONMED Corporation
Johnson & Johnson
KARL STORZ GmbH & Co. KG
Olympus Corporation
Richard Wolf GmbH
Stryker Corporation
Others

Request Report Methodology:https://www.futuremarketinsights.com/request-report-methodology/rep-gb-1386

Key Segments:

By Product Type:

Arthroscopes and Visualization Systems
Arthroscopic Resection Systems
Arthroscopic Fluid Management Systems
Arthroscopic Implants
- Knee Implants
- Shoulder Implants
- Hip Implants
- Other Implants
Arthroscopy Radiofrequency (RF) Systems
Arthroscopic Drills and Fixation Systems
Other Arthroscopy Instruments and Accessories

By Procedure Type:

Shoulder Arthroscopy
Hip Arthroscopy
Knee Arthroscopy
Elbow Arthroscopy
Small Joints Arthroscopy
Others

Author By:

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube